The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    New sunscreen will be available this fall

    The Food and Drug Administration approved Anthelios SX today. It is a moisturizer and sun blocker from L’Oreal.

    Anthelios SX will contains avobenzone (blocks UVA) and octocrylenem (blocks UVB). Both ingredients are already found in sunscreens sold in the U.S. What’s new about Anthelios SX is that it will also contain ecamsule, which blocks short UVA and has not previously been sold in the U.S. Ecamsule has been marketed in Europe and Canada as Mexoryl SX since 1993.

    UVA rays account for approximately 95% of all ultraviolet energy. They can cause permanent damage to DNA. UVA passes through glass, and the effects do not show right away. By comparison, UVB rays cause sunburn but do not penetrate as deeply as UVA rays.

    The product will be available in the fall, just in time for ski season.

    7/24/06 15:03 JR

    Leave a Comment

    You must be logged in to post a comment.